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Background/aim: The effects of pericardium 6 (P6) electrical stimulation in patients at risk of postoperative nausea and vomiting
(PONV) following laparoscopic surgery were evaluated.
Materials and methods: Eighty patients for laparoscopic surgery with at least one of the determined risks (nonsmoker, female, previous
PONV/motion sickness, or postoperative opioid use) were randomized into either an active or sham group. At the end of surgery, Reletex
electrical acustimulation was placed at the P6 acupoint. The active group had grade 3 strength and the sham group had inactivated
electrodes covered by silicone. It was worn for 24 h following surgery. PONV scores were recorded.
Results: The active group had significantly shorter durations of surgery and lower PONV incidence over 24 h (35.1% versus 64.9%, P =
0.024) and this was attributed to the lower incidence of nausea (31.4% versus 68.6%, P = 0.006). The overall incidence of vomiting was
not significantly different between the groups, but it was higher in the sham group of patients with PONV risk score 3 (23.9%, P = 0.049).
Conclusion: In patients at high risk for PONV, P6 acupoint electrical stimulation lowers the PONV incidence by reducing the nausea
component. However, this reduction in nausea is not related to increasing PONV risk scores.
Key words: P6, acupoint electrical stimulation, postoperative nausea and vomiting

1. Introduction
Postoperative nausea and vomiting (PONV) is a common
complication following surgery and anesthesia (1,2). Before
the 1960s, when older inhalational anesthetic agents such
as ether and cyclopropane were widely used, the incidence
of vomiting was as high as 60% (3). Improved anesthetic
techniques, along with newer generations of antiemetics
and shorter-acting anesthetic drugs, have reduced the
overall incidence of PONV to approximately 30% (4).
Nonetheless, PONV still occurs in as many as 70% of highrisk patients (5).
It is estimated that one episode of vomiting prolongs
postanesthesia care unit stay by approximately 25 min (6).
Even incidences of mild PONV can lead to an unanticipated
hospital admission, greatly increased medical costs, and
reduced patient satisfaction (7).
There are several centrally acting antiemetics currently
available for the prophylaxis of nausea and vomiting.
Unfortunately, antiemetics are not always successful. In
addition, antiemetic pharmacological agents are associated
* Correspondence: shereen_tang@yahoo.com
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with adverse side effects that vary from lethargy to
extrapyramidal signs and symptoms (2). These concerns
have led researchers to investigate alternative approaches,
such as stimulation of an acupuncture point, which had
anecdotally been reported to decrease nausea and vomiting
contributed by a variety of conditions (8). The acupuncture
point can be stimulated using various methods. Application
of pressure onto the pericardium 6 (P6) area (acupoint
pressure), needling of the P6 point (acupuncture), and
transcutaneous electrical nerve stimulation (TENS) are
some of the techniques described (8–10).
In this study, we compared the effectiveness of P6
acupoint electrical stimulation in preventing PONV
following laparoscopic surgery.
2. Materials and methods
This prospective, randomized, controlled, and observerblinded clinical trial was carried out after obtaining our
institution’s ethics committee approval and patients’
informed consent. Patients above 18 years of age classified
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as physical status I or II according to the American Society
of Anesthesiologists (ASA) with at least one additional
PONV risk factor, as suggested by Apfel et al. (5,11,12), who
were scheduled for laparoscopic surgery were recruited
into the study. These risk factors were: nonsmoker, female,
history of PONV/motion sickness, and postoperative
opioid use. Patients who were pregnant, dependent on a
cardiac pacemaker or implanted cardioverter/defibrillator,
allergic to nickel/chrome, anticipated to have a difficult
airway or require postoperative ventilator support, known
to have peripheral neuropathy, or with a body mass index
(BMI) of >35 kg/m2 were excluded.
Following recruitment, patient risk factors for PONV,
including laparoscopy surgery, were summed up with
a risk score modified from Apfel et al. (5,11,12). Each
risk factor was given a score of one point. Therefore, the
minimum PONV risk score was 2.
The patients were randomly allocated to either an
active group (acustimulation group) or a sham group
(sham acustimulation group) by using a random sequence
of computer-generated numbers. The investigators
responsible for data collection were blinded to the
treatments administered to the study patients.
TENS was provided by the commercially available
Reletex device. It is an FDA-approved piece of equipment
commonly used as an adjunct to antiemetics in PONV
prophylaxis and treatment. The portable, watch-like
device is lightweight (34 g), battery-powered (two 3 V
lithium coin cells), and capable of delivering current at 5
mA to 40 mA gradable in 5 strengths. This transdermal
neuromodulation device generates specific pulses in
waveform, frequency, and intensity for stimulation of
the median nerve. The device’s surface, which has direct
contact with the skin, has two flat metal electrodes through
which electrical stimulation is applied transcutaneously.
At the end of surgery, the Reletex device was applied
over the acupoint area known as P6 on the dominant
upper extremity of the active group. The P6 is the sixth
point on the pericardial meridian, located on the anterior
surface of the forearm, 2–3 cm proximal to the distal wrist
crease between the tendons of the flexor carpi radialis
and the palmaris longus (13). The device was set at grade
3 strength. In the sham group, the inactivated Reletex
device was applied to the P6 acupoint. It was inactivated
by placing a silicone cover over the electrodes, which was
invisible to both patients and investigators. The devices
were worn for 24 h after surgery.
In the operating theater, an intravenous (IV) cannula
was inserted in the nondominant hand to avoid interfering
with the acustimulation device. IV dexamethasone 4.0
mg was given prior to induction of anesthesia. General
anesthesia was induced with IV propofol 1.5–2.5 mg/
kg, IV fentanyl 1 µg/kg, and IV rocuronium 0.6–1.0

mg/kg. Anesthesia was maintained by sevoflurane at
a MAC of 0.8–1.2 in an oxygen:air mixture titrated
to FiO2 of 0.4–0.6. All patients received IV morphine
0.05–0.1 mg/kg after induction of anesthesia and prior
to surgical incision. Carbon dioxide (CO2) gas was used
to create surgical pneumoperitoneum at intraabdominal
pressure maintained at less than 15 cm H2O. It was
fully evacuated at the end of the operation. Following
decompression of pneumoperitoneum, infiltration with
0.5% levobupivacaine in a 10 mL solution to the surgical
wounds was given. IV parecoxib 40 mg was given 30 min
before extubation and was repeated at 8 h after extubation.
Residual neuromuscular blockade was antagonized with
IV neostigmine and IV atropine. Tablet paracetamol (1 g)
at 6-h intervals was prescribed once patients could tolerate
oral administrations in the postoperative period. There
was no further opioid administration in the ward.
Patients were evaluated for occurrence and severity of
nausea and vomiting, and for pain, in the recovery room
(0 h) and at 2, 6, 12, and 24 h postoperatively. PONV
assessment was done using a 3-point scale (0 = no nausea
and vomiting, 1 = mild to moderate nausea, and 2 = severe
nausea and vomiting needing treatment). Rescue therapy
with 1 mg granisetron was administered to patients
who experienced severe nausea and vomiting. Pain was
assessed with a visual analog scale (VAS), whereby 0 =
no pain and 10 = most painful. Recruited patients were
briefed on the process of VAS measurement. Patients who
required postoperative opioids as a rescue analgesia were
excluded from the study.
Sample size was calculated based on Frey et al.,
whereby a total of 80 patients were required in order to
have 80% power with a significance level of 0.05% to detect
a difference in the incidence of PONV at 33% between
groups after considering a 20% drop-out rate (14). All the
data were analyzed using SPSS 21.0. Parametric variables
were compared using Student’s t-test. Categorical variables
were compared using the chi-square test. P < 0.05 was
considered statistically significant.
3. Results
Eighty-five patients were recruited into the study. Fortytwo patients were randomly allocated into the active
acustimulation group and 43 patients into the sham
acustimulation group. Four patients were excluded due
to the conversion of laparoscopic to open surgery and
one patient was given an opioid postoperatively for pain
treatment. Of the 80 patients who completed the study, 40
patients were in the active group and 40 patients were in
the sham group. Patient demographic characteristics and
factors likely to influence PONV were not significantly
different between the active and sham groups. Duration of
surgery was found to be significantly shorter in the active
group (Table).
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Table. Demographic data, duration of surgery, and PONV risk factors. The values are expressed as mean ± SD and number (%) where
appropriate.
Sham group (n = 40)

Active group (n = 40)

46.5 ± 14.3

41.5 ± 13.8

Sex (male : female)

7 : 33

12 : 28

BMI (kg/m )

22.8 ± 2.8

23.3 ± 2.9

Duration of surgery (min)

112.8 ± 52.2*

76.8 ± 44.9*

Nonsmokers (%)

(85.0)

(80.0)

History of PONV/motion sickness (%)

(12.5)

(17.5)

2

10

17

3

28

18

4

2

5

Age (years)

2

Total risk score (n)

*Significant at P < 0.05.

Overall incidence of PONV was 46.3%. The active
group had significantly lower PONV incidence over 24
h than the sham group (35.1% versus 64.9%, P = 0.024).
This was mainly due to the significantly lower incidence of
nausea over 24 h in the active group (31.4% versus 68.6%,
P = 0.006). However, the incidence of vomiting over 24 h
was not significantly different between groups (Figures 1
and 2).
Patients with a PONV risk score of 2 and above were not
statistically different in their incidence of nausea between
the two groups. However, the incidence of vomiting was
significantly higher (23.9% versus 4.3%, P = 0.049) in the
sham group with a PONV risk score of 3 (Figures 3 and 4).
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Figure 1. Incidence of postoperative nausea in sham and active
groups at 0–24 h. *Significant at P < 0.05.
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4. Discussion
Known patient risk factors that contribute towards PONV
include young, female adults with previous PONV or
100%

100%

50%

Nine patients (22.5%) in the active group required
granisetron rescue therapy, compared to 15 patients
(37.5%) in the sham group. However, this was not
statistically significant (P = 0.222).
The pain scores between the sham and active groups
were not significantly different in the first 24 postoperative
h. There were no adverse effects noted in this study, such
as allergic reaction to the Reletex device, rashes, or skin
scalding.
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Figure 2. Incidence of postoperative vomiting in sham and
active groups at 0–24 h.
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Figure 3. Incidence of postoperative nausea in subgroups of
PONV risk score.

Figure 4. Incidence of postoperative vomiting in subgroups of
PONV risk score. *Significant at P < 0.05.

motion sickness who are nonsmokers. The anesthetic plan,
which utilizes opioids, nitrous oxide, and inhalational
agents, also plays an important role in determining the
incidence of PONV (15). However, of the many surgery
types initially associated with PONV, only cholecystectomy,
laparoscopic procedures, and gynecological surgery are
probably independent predictors of PONV (16). PONV
remains an important anesthetic issue, as it may result
in a range of morbidities, including reduced patient
satisfaction, delayed hospital discharge, unexpected
hospital admission, fluid and electrolyte disturbances,
wound dehiscence, bleeding, pulmonary aspiration, and
esophageal rupture (15).
Using the Reletex acustimulation device, we
demonstrated that TENS application at the P6 acupoint
significantly reduced the incidence of postoperative nausea.
This therapeutic effect was observed regardless of the
PONV risk score in patients after laparoscopic surgery.
Sixty-five percent of the patients in the sham group had
significantly higher incidence of PONV, compared to 35.1%
in the active group. These results are similar to previously
published results regarding acupoint pressure stimulation
(8,14,17–21). We analyzed the incidence of nausea and
vomiting separately in order to assess the efficacy of P6
acupoint stimulation. Patients in the active group had
significantly reduced nausea episodes for up to 12 h in the
postoperative period. We did not find significant differences
between groups in the incidence of vomiting. Similarly, a
sham-controlled prophylaxis study by Zarate et al. using
the Relief-Band acustimulation device demonstrated
only an antinausea, rather than antivomiting, effect
following laparoscopic cholecystectomy (22). According to
Doubravska et al., the incidences of postoperative nausea
and vomiting were 13.4% and 8.6%, respectively (23). In

view of the lower incidence of vomiting compared to nausea,
a study with a larger sample size will be better able to detect
the effectiveness of nonpharmacological intervention, such
as the P6 acupoint stimulation, at preventing postoperative
vomiting.
Our results suggested that P6 acupoint electrical
stimulation is more effective when applied to patients at
high risk for PONV. High risk is usually defined as having
three or more risk factors for PONV, as suggested by
Apfel et al. (5,11,12). Patients at moderate risk for PONV
(with only two risk factors present) are less likely to show
favorable response to treatment, as the incidence of PONV
itself is lower (14). Patients in our active group with a
PONV risk score of 3 had a significantly lower incidence of
vomiting, but not nausea. The efficacy of P6 acustimulation
at reducing the incidence of vomiting is more likely as the
number of risk factors for PONV increases. Our study was
unable to demonstrate similar findings when the PONV
risk score was at least 4. The low number of patients
with very high PONV risk scores may have resulted in
insufficient power to detect an effect.
The optimal timing to implement P6 acupoint
stimulation is still debatable when attempting to prevent
the occurrence of PONV (24). Frey et al. demonstrated
no differences between pre- and postoperative acupoint
stimulation in the incidence of PONV (14). The same
authors proceeded to mention that patients in the sham
group had higher incidences of PONV, necessitating a
longer duration of therapy until the 24-h postoperative
period was over (14). On the other hand, White et al.
showed the best effect on PONV prevention was obtained
when acustimulation was administered until 72 h after
surgery (21). Kotani et al. reported that preoperative
application of an intradermal acupuncture needle, left
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in situ for 4 postoperative days, reduced nausea and
vomiting significantly after abdominal surgery (25). The
PONV incidence over 24 h in our sham group was high
at 64.9%. Thus, our active group patients benefited most
from the Reletex device applied over a 24 h period. Along
with timing, the postoperative P6 acupoint stimulation
duration is equally important when considering PONV
prevention strategy.
Following our institutional ethics committee with
regards to the increased anticipated risk of developing
PONV in laparoscopic surgeries, we precluded the
omission of antiemetic prophylaxis from this study.
IV dexamethasone 4 mg was selected as the routine
antiemetic prophylaxis. It has been found to be a costeffective prophylactic antiemetic, with a number needed
to treat of 4.7 for PONV (26–28). Despite this antiemetic
prophylaxis, the overall incidence of PONV in our sham
group was reported at 64.9%. However, recent studies have
documented the benefits of routine antiemetic prophylaxis
for surgeries with recognized significant risk of developing
PONV (7,29,30). Prophylaxis with either dual or more
antiemetic drug regimens are justified in patients with
more risk factors for PONV (30,31). Nonetheless, the
possibility of adverse drug interactions may increase as a
function of the number of drugs administered (32).
Our results showed significantly reduced incidence of
nausea in the active group. This may have been confounded
by the sham group having a significantly longer duration
of surgery (76.8 min versus 112.8 min). According to
Doubvraska et al., laparoscopic surgery was postulated
as a risk factor of PONV as a result of carbon dioxide
insufflation into the intestines, increased abdominal
pressure, and vagus nerve irritation (23). Longer duration
of surgical pneumoperitoneum is associated with increased
exposure to these proemetic conditions.
Kaya et al. demonstrated similar efficacy in PONV
prophylaxis when comparing droperidol with pressure
effects to 6% dextran injections at the P6 acupoint (33).
Despite inactivation of the device in our sham group, there
is unavoidable continuous pressure on the P6 area and this
can create an undesirable acupressure effect. However,

minimization of the pressure effect was possible due to the
device’s unique build. The Reletex device is incorporated
with a flattened posterior surface with stimulating
electrodes protruding only 1 mm from its surface. These
findings were supported by patients in the sham group
using similar wrist bands in acupressure studies (9,10).
Identical acustimulation units were utilized throughout
this study. Sham group patients received inactivated units,
which were intended to produce a dummy effect at the
P6 acupoint. Regardless of grouping, all patients were
briefed similarly about the Reletex device, which produces
a tingling sensation that they may perceive. However, we
acknowledged that blinding can be further improved with
application of the Reletex device at nonacupoint sites,
which simulates a placebo effect. Nonetheless, these sites
are also associated with transmission of electrical impulses
to the P6 area (22).
Apfel et al. described a well-validated simplified PONV
risk score (5,11,12). Our study, on the other hand, used
a nonvalidated risk score, since we added laparoscopic
surgery as a factor. This was based on the work of Apfel et
al. and Gan et al. (16,34). Both studies concluded that of
all the surgery types, only cholecystectomy, gynecologic,
and laparoscopic surgeries are probably risk factors that
independently increase the risk for PONV (16,34).
In conclusion, P6 acupoint electrical stimulation is a
useful nonpharmacological adjunct to antiemetic drugs
for preventing postoperative nausea for up to 12 h in
adults. However this reduction in nausea is not related
to increased PONV risk scores. Future studies should
be designed to evaluate the relative cost-effectiveness of
acustimulation and prophylactic antiemetic therapies
when they are administered separately or in combination
in preventing both postoperative nausea as well as
vomiting (17).
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